First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | , , , , , , , , , , , , , |
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2010
|
| In: |
The European journal of cancer
Year: 2010, Volume: 46, Issue: 18, Pages: 3184-3191 |
| ISSN: | 0959-8049 |
| Online Access: |
|
| Author Notes: | $hM. Kaufmann, N. Maass, S.D. Costa, A. Schneeweiss, S. Loibl, M. W. Sütterlin, I. Schrader, B. Gerber, W. Bauer, W. Wiest, O. Tomé, A. Distelrath, V. Hagen, A. Kleine-Tebbe, E. Ruckhaeberle, K. Mehta, G. von Minckwitz, for the GBG-39 trialists |
Search Result 1